U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449494) titled 'Live Birth Rate After First Embryo Transfer With or Without Glucocorticoid Sensitivity Testing' on Feb. 27.
Brief Summary: This retrospective single-center observational cohort study evaluates live birth rates after the first embryo transfer following immune assessment in infertile women with documented uterine immune overactivation.
In routine clinical practice, glucocorticoids represent first-line therapy for immune overactivation. Some patients underwent glucocorticoid sensitivity testing prior to embryo transfer based solely on standard clinical practice and patient preference. In cases of demonstrated glucocorticoid resistance...